Literature DB >> 12882719

Urethral stents in benign prostate hyperplasia.

Robert F Donnell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882719     DOI: 10.1007/s11934-003-0085-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


× No keyword cloud information.
  34 in total

1.  Anatomic limitations of prostatic urethra in using cylindrical stents.

Authors:  E J Milroy; D Rickards
Journal:  J Endourol       Date:  1997-12       Impact factor: 2.942

2.  [Endourethral spiral--an alternative to continuous catheterization?].

Authors:  P G Fabricius; M Matz; H Zepnick
Journal:  Z Arztl Fortbild (Jena)       Date:  1983

3.  Expansion and bioabsorption of the self-reinforced lactic and glycolic acid copolymer prostatic spiral stent.

Authors:  S Laaksovirta; M Talja; T Välimaa; T Isotalo; P Törmälä; T L Tammela
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

4.  Late complications of Prostakath treatment for benign prostatic hypertrophy.

Authors:  P Rosenkilde; J F Pedersen; H H Meyhoff
Journal:  Br J Urol       Date:  1991-10

5.  Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.

Authors:  M I Anjum; R Chari; A Shetty; M Keen; J H Palmer
Journal:  Br J Urol       Date:  1997-12

6.  Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy.

Authors:  K Hu; K Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

7.  Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.

Authors:  G Guazzoni; F Bergamaschi; F Montorsi; P Consonni; L Galli; V Matozzo; P Rigatti
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

8.  The intraprostatic spiral: a new device for insertion with the patient under local anesthesia and with ultrasonic guidance with 3 months of followup.

Authors:  J Nordling; H H Holm; P Klarskov; K K Nielsen; J T Andersen
Journal:  J Urol       Date:  1989-09       Impact factor: 7.450

9.  Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia.

Authors:  S A Kaplan; E T Goluboff; C A Olsson; P A Deverka; J J Chmiel
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

10.  The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.

Authors:  J E Oesterling; S A Kaplan; H B Epstein; A J Defalco; P K Reddy; M B Chancellor
Journal:  Urology       Date:  1994-09       Impact factor: 2.649

View more
  1 in total

Review 1.  Drug-eluting metallic stents in urology.

Authors:  Panagiotis S Kallidonis; Ioannis S Georgiopoulos; Iason D Kyriazis; Abdulrahman M Al-Aown; Evangelos N Liatsikos
Journal:  Indian J Urol       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.